ZyVersa Therapeutics
(OTC) ZVSA
ZyVersa Therapeutics Financials at a Glance
Market Cap
$1.62M
Revenue (TTM)
$0.00
Net Income (TTM)
$702.85M
EPS (TTM)
$-3.83
P/E Ratio
-0.05
Dividend
$0.00
Beta (Volatility)
0.32 (Low)
Dividend
$0.00
Beta (Volatility)
0.32 (Low)
Price
$0.20
Volume
29,654
Open
$0.19
Price
$0.20
Volume
29,654
Open
$0.19
Previous Close
$0.20
Daily Range
$0.19 - $0.23
52-Week Range
$0.11 - $1.67
Dividend
$0.00
Beta (Volatility)
0.32 (Low)
Price
$0.20
Volume
29,654
Open
$0.19
Previous Close
$0.20
Daily Range
$0.19 - $0.23
52-Week Range
$0.11 - $1.67
ZVSA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ZyVersa Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
Stephen C. Glover
Website
www.zyversa.comHeadquarters
Weston, FL 33326, US
ZVSA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-113%
Return on Capital
0%
Return on Assets
-2%
Earnings Yield
-20.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.62M
Shares Outstanding
8.10M
Volume
29.65K
Short Interest
0.00%
Avg. Volume
36.40K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$6.84M
EBITDA
$25.29M
Operating Cash Flow
$5.11B
Capital Expenditure
$0.00
Free Cash Flow
$5.11B
Cash & ST Invst.
$101.78M
Total Debt
$0.00
ZyVersa Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$1.62M
N/A
Market Cap/Employee
$231.90K
N/A
Employees
7
N/A
Net Income
$678.57M
-47629.7%
EBITDA
$426.75K
+66.8%
Quarterly Fundamentals
Net Cash
$101.78M
+6548.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-2.02%
N/A
Return on Invested Capital
0.06%
N/A
Free Cash Flow
$413.69M
-33681.3%
Operating Cash Flow
$413.69M
-33681.3%